• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下一代测序是分析生存运动神经元 1 (SMN1) 基因外显子 7 缺失的高度可靠方法。

Next generation sequencing is a highly reliable method to analyze exon 7 deletion of survival motor neuron 1 (SMN1) gene.

机构信息

Tianjin Medical Laboratory, BGI-Tianjin, BGI-Shenzhen, Central Avenue 55, Airport Business Park East Building E3, Tianjin, 300308, China.

BGI Genomics, BGI-Shenzhen, Bei Shan Industrial Zone, Yantian District, Shenzhen, 518083, Guangdong, China.

出版信息

Sci Rep. 2022 Jan 7;12(1):223. doi: 10.1038/s41598-021-04325-1.

DOI:10.1038/s41598-021-04325-1
PMID:34997153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8741787/
Abstract

Spinal muscular atrophy (SMA) is one of the most common and severe genetic diseases. SMA carrier screening is an effective way to identify couples at risk of having affected children. Next-generation sequencing (NGS)-based expanded carrier screening could detect SMN1 gene copy number without extra experiment and with high cost performance. However, its performance has not been fully evaluated. Here we conducted a systematic comparative study to evaluate the performance of three common methods. 478 samples were analyzed with multiplex ligation probe amplification (MLPA), real-time quantitative polymerase chain reaction (qPCR) and NGS, simultaneously. Taking MLPA-based results as the reference, for 0 copy, 1 copy and ≥ 2 copy SMN1 analysis with NGS, the sensitivity, specificity and precision were all 100%. Using qPCR method, the sensitivity was 100%, 97.52% and 94.30%, respectively; 98.63%, 95.48% and 100% for specificity; and 72.72%, 88.72% and 100% for precision. NGS repeatability was higher than that of qPCR. Moreover, among three methods, NGS had the lowest retest rate. Thus, NGS is a relatively more reliable method for SMN1 gene copy number detection. In expanded carrier screening, compared with the combination of multiple methods, NGS method could reduce the test cost and simplify the screening process.

摘要

脊髓性肌萎缩症(SMA)是最常见和最严重的遗传疾病之一。SMA 携带者筛查是识别有患病子女风险的夫妇的有效方法。基于下一代测序(NGS)的扩展携带者筛查可以在不进行额外实验的情况下检测 SMN1 基因拷贝数,并且具有较高的性价比。然而,其性能尚未得到充分评估。在这里,我们进行了一项系统的比较研究,以评估三种常用方法的性能。同时使用多重连接探针扩增(MLPA)、实时定量聚合酶链反应(qPCR)和 NGS 分析了 478 个样本。以 MLPA 为参考,对于 NGS 的 0 拷贝、1 拷贝和≥2 拷贝 SMN1 分析,其敏感性、特异性和精度均为 100%。使用 qPCR 方法,其敏感性分别为 100%、97.52%和 94.30%;特异性分别为 98.63%、95.48%和 100%;精度分别为 72.72%、88.72%和 100%。NGS 的重复性高于 qPCR。此外,在这三种方法中,NGS 的复测率最低。因此,NGS 是一种用于检测 SMN1 基因拷贝数相对更可靠的方法。在扩展携带者筛查中,与多种方法的组合相比,NGS 方法可以降低检测成本并简化筛查过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00de/8741787/2c045adbf2b5/41598_2021_4325_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00de/8741787/596b01a7a55f/41598_2021_4325_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00de/8741787/dfea2fee9eab/41598_2021_4325_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00de/8741787/2c045adbf2b5/41598_2021_4325_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00de/8741787/596b01a7a55f/41598_2021_4325_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00de/8741787/dfea2fee9eab/41598_2021_4325_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00de/8741787/2c045adbf2b5/41598_2021_4325_Fig3_HTML.jpg

相似文献

1
Next generation sequencing is a highly reliable method to analyze exon 7 deletion of survival motor neuron 1 (SMN1) gene.下一代测序是分析生存运动神经元 1 (SMN1) 基因外显子 7 缺失的高度可靠方法。
Sci Rep. 2022 Jan 7;12(1):223. doi: 10.1038/s41598-021-04325-1.
2
The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing.下一代基于人群的脊髓性肌萎缩症携带者筛查:通过大规模平行测序进行全面的泛种族SMN1拷贝数和序列变异分析。
Genet Med. 2017 Aug;19(8):936-944. doi: 10.1038/gim.2016.215. Epub 2017 Jan 26.
3
Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.将下一代测序的脊髓性肌萎缩症分析纳入神经肌肉疾病的综合多基因panel 中。
Genet Test Mol Biomarkers. 2020 Oct;24(10):616-624. doi: 10.1089/gtmb.2019.0282. Epub 2020 Jul 23.
4
Evaluating the performance of four assays for carrier screening of spinal muscular atrophy.评估四种脊髓性肌萎缩症携带者筛查检测方法的性能。
Clin Chim Acta. 2023 Aug 1;548:117496. doi: 10.1016/j.cca.2023.117496. Epub 2023 Jul 20.
5
Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.多重液滴数字 PCR 方法适用于新生儿筛查、携带者状态和脊髓性肌萎缩症的评估。
Clin Chem. 2018 Dec;64(12):1753-1761. doi: 10.1373/clinchem.2018.293712. Epub 2018 Oct 23.
6
Evaluating the clinical efficacy of a long-read sequencing-based approach for carrier screening of spinal muscular atrophy.评估基于长读测序的脊髓性肌萎缩症携带者筛查方法的临床疗效。
Hum Genomics. 2024 Sep 29;18(1):110. doi: 10.1186/s40246-024-00676-8.
7
Carrier Screening and Diagnosis for Spinal Muscular Atrophy Using Droplet Digital PCR Versus MLPA: Analytical Validation and Early Test Outcome.使用液滴数字 PCR 与 MLPA 进行脊髓性肌萎缩症的携带者筛查和诊断:分析验证和早期检测结果。
Genet Test Mol Biomarkers. 2024 May;28(5):207-212. doi: 10.1089/gtmb.2023.0073. Epub 2024 Mar 27.
8
SMN1 gene copy number analysis for spinal muscular atrophy (SMA) in a Turkish cohort by CODE-SEQ technology, an integrated solution for detection of SMN1 and SMN2 copy numbers and the "2+0" genotype.通过CODE-SEQ技术对土耳其队列中的脊髓性肌萎缩症(SMA)进行SMN1基因拷贝数分析,这是一种用于检测SMN1和SMN2拷贝数以及“2+0”基因型的综合解决方案。
Neurol Sci. 2020 Sep;41(9):2575-2584. doi: 10.1007/s10072-020-04365-x. Epub 2020 Apr 6.
9
Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene.脊髓性肌萎缩症患者的混合 SMN 基因的临床表型。
Brain Dev. 2021 Feb;43(2):294-302. doi: 10.1016/j.braindev.2020.09.005. Epub 2020 Oct 6.
10
Universal fluorescent multiplex PCR and capillary electrophoresis for evaluation of gene conversion between SMN1 and SMN2 in spinal muscular atrophy.通用荧光多重 PCR 和毛细管电泳评估脊髓性肌萎缩症中 SMN1 和 SMN2 之间的基因转换。
Anal Bioanal Chem. 2010 Jul;397(6):2375-83. doi: 10.1007/s00216-010-3761-1. Epub 2010 Jun 19.

引用本文的文献

1
Copy Number Association with Spinal Muscular Atrophy Severity: Insights from Colombian Patients.拷贝数与脊髓性肌萎缩严重程度的关联:来自哥伦比亚患者的见解
J Clin Med. 2024 Oct 25;13(21):6402. doi: 10.3390/jcm13216402.
2
Whole-exome sequencing as the first-tier test for patients in neonatal intensive care unit: a Chinese single-center study.对新生儿重症监护病房患者进行全外显子组测序作为一线检测:一项中国单中心研究。
BMC Pediatr. 2024 May 22;24(1):351. doi: 10.1186/s12887-024-04820-0.
3
Analysis of spinal muscular atrophy carrier screening results in 32,416 pregnant women and 7,231 prepregnant women.

本文引用的文献

1
SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals.脊髓性肌萎缩症的鉴定:来自一项针对2000多名个体的脊髓性肌萎缩症赞助检测项目的临床和分子研究结果
Front Neurol. 2021 May 6;12:663911. doi: 10.3389/fneur.2021.663911. eCollection 2021.
2
A rapid molecular diagnostic method for spinal muscular atrophy.用于脊髓性肌萎缩症的快速分子诊断方法。
J Neurogenet. 2021 Mar;35(1):29-32. doi: 10.1080/01677063.2020.1853721. Epub 2020 Dec 17.
3
Development and validation of a 4-color multiplexing spinal muscular atrophy (SMA) genotyping assay on a novel integrated digital PCR instrument.
对32416名孕妇和7231名孕前女性进行脊髓性肌萎缩症携带者筛查结果分析。
Front Neurol. 2024 Apr 9;15:1357476. doi: 10.3389/fneur.2024.1357476. eCollection 2024.
4
Screening of Spinal Muscular Atrophy Carriers and Prenatal Diagnosis in Pregnant Women in Yancheng, China.中国盐城孕妇脊髓性肌萎缩症携带者筛查及产前诊断
Biochem Genet. 2025 Apr;63(2):1541-1550. doi: 10.1007/s10528-024-10775-9. Epub 2024 Apr 6.
5
Carrier screening for spinal muscular atrophy in 22913 Chinese reproductive age women.对 22913 名中国育龄期妇女进行脊髓性肌萎缩症携带者筛查。
Mol Genet Genomic Med. 2024 Jan;12(1):e2359. doi: 10.1002/mgg3.2359.
6
Current Advances in Genetic Testing for Spinal Muscular Atrophy.脊髓性肌萎缩症基因检测的当前进展
Curr Genomics. 2023 Dec 20;24(5):273-286. doi: 10.2174/0113892029273388231023072050.
7
The First Registered Type 0 Spinal Muscular Atrophy Patient in Latvia: Call for Change in Prenatal Diagnostic Procedures.拉脱维亚首例注册的0型脊髓性肌萎缩症患者:呼吁改变产前诊断程序。
Case Rep Med. 2023 Jun 1;2023:3480298. doi: 10.1155/2023/3480298. eCollection 2023.
8
Screening and prenatal diagnosis of survival motor neuron gene deletion in pregnant women in Zhaoqing city, Guangdong Province.广东省肇庆市孕妇生存运动神经元基因缺失的筛查和产前诊断。
BMC Med Genomics. 2023 Mar 1;16(1):39. doi: 10.1186/s12920-023-01468-0.
9
Spinal muscular atrophy.脊髓性肌萎缩症。
Nat Rev Dis Primers. 2022 Aug 4;8(1):52. doi: 10.1038/s41572-022-00380-8.
10
Cas14a1-Mediated Nucleic Acid Diagnostics for Spinal Muscular Atrophy.Cas14a1 介导的脊髓性肌萎缩症核酸诊断。
Biosensors (Basel). 2022 Apr 23;12(5):268. doi: 10.3390/bios12050268.
新型一体化数字 PCR 仪器上开发和验证用于脊髓性肌萎缩症(SMA)基因分型的 4 色多重荧光定量 PCR 检测方法。
Sci Rep. 2020 Nov 16;10(1):19892. doi: 10.1038/s41598-020-76893-7.
4
SMN1 copy-number and sequence variant analysis from next-generation sequencing data.从下一代测序数据中分析 SMN1 拷贝数和序列变异。
Hum Mutat. 2020 Dec;41(12):2073-2077. doi: 10.1002/humu.24120. Epub 2020 Oct 14.
5
Analytical validation of the droplet digital PCR assay for diagnosis of spinal muscular atrophy.用于脊髓性肌萎缩症诊断的液滴数字PCR检测法的分析验证
Clin Chim Acta. 2020 Nov;510:787-789. doi: 10.1016/j.cca.2020.09.024. Epub 2020 Sep 19.
6
NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study.基于 NGS 的中国 10585 对不同种族夫妇的脊髓性肌萎缩症携带者筛查:一项泛种族研究。
Eur J Hum Genet. 2021 Jan;29(1):194-204. doi: 10.1038/s41431-020-00714-8. Epub 2020 Sep 3.
7
Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.将下一代测序的脊髓性肌萎缩症分析纳入神经肌肉疾病的综合多基因panel 中。
Genet Test Mol Biomarkers. 2020 Oct;24(10):616-624. doi: 10.1089/gtmb.2019.0282. Epub 2020 Jul 23.
8
Genetic ancestry analysis on >93,000 individuals undergoing expanded carrier screening reveals limitations of ethnicity-based medical guidelines.对超过 93000 名接受扩展携带者筛查的个体进行遗传祖先分析,揭示了基于种族的医学指南的局限性。
Genet Med. 2020 Oct;22(10):1694-1702. doi: 10.1038/s41436-020-0869-3. Epub 2020 Jun 29.
9
Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach.在普通人群中进行携带者筛查的临床经验:支持全面的泛种族方法。
Genet Med. 2020 Aug;22(8):1320-1328. doi: 10.1038/s41436-020-0807-4. Epub 2020 May 5.
10
Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in 13,069 Chinese Pregnant Women.13069 例中国孕妇的脊髓性肌萎缩症携带者筛查与产前诊断。
J Mol Diagn. 2020 Jun;22(6):817-822. doi: 10.1016/j.jmoldx.2020.03.001. Epub 2020 Mar 20.